Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial (Q39235777)

10 September 2017

title

Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1514724

4 October 2022

1 reference

1 reference

C. Duarte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1514724

4 October 2022

F. Dunaway

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1514724

4 October 2022

L. Turner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1514724

4 October 2022

J. Aldag

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1514724

4 October 2022

R. Frederick

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1514724

4 October 2022

language of work or name

English

0 references

publication date

1 September 1992

1 reference

Annals of Emergency Medicine

10 September 2017

published in

1 reference

10 September 2017

volume

21

1 reference

10 September 2017

issue

9

1 reference

10 September 2017

page(s)

1116-1121

1 reference

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Drug abuse in migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

A review of current drugs for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Treatment review: non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Do non-steroidal anti-inflammatory agents have a role in the treatment of migraine headaches?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Pathogenesis of migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Pharmacology of antimigraine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Platelets and prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Treatment of acute migraine attack: ibuprofen and placebo compared

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled crossover clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Effectiveness of Oral Diclofenac in the Acute Treatment of Common Migraine Attacks: A Double-Blind Study Versus Placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

The analgesic and anti-inflammatory profile of (+/-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS-37619)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Ketorolac, a new non-opioid analgesic: a single-blind trial versus buprenorphine in pain after orthopaedic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

A double-blind single dose comparison of intramuscular ketorolac tromethamine and pethidine in the treatment of renal colic

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Effects of ketorolac tromethamine on hemostasis in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

The effects on ventilation of ketorolac in comparison with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980654-7

7 January 2021

10.1016/S0196-0644(05)80654-7

Identifiers

DOI

1 reference

10 September 2017

1 reference